Intensive Postremission Chemotherapy in Adults with Acute Myeloid Leukemia

J. Mayer, Robert; B. Davis, Roger; A. Schiffer, Charles; Berg, Deborah; L. Powell, Bayard; Schulman, Philip; Omura, George; O. Moore, Joseph; Ross McIntyre, O.; Frei, E

doi:10.1056/nejm199410063311402

Public

Intensive Postremission Chemotherapy in Adults with Acute Myeloid Leukemia

Published in New England Journal of Medicine • Oct 6, 1994

Authors:

Robert J. Mayer

Roger B. Davis

Charles A. Schiffer

Abstract

BACKGROUND: About 65 percent of previously untreated adults with primary acute myeloid leukemia (AML) enter complete remission when treated with cytarabine and an anthracycline. However, such responses are rarely durable when conventional postremission therapy is administered. Uncontrolled trials ha...

Subject

Medicine

Cytarabine

Myeloid leukemia

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!